Oxazepine
Oxazepine is an antifungal agent belonging to the class of seven-membered heterocyclic azepine derivatives. Oxazepine exerts inhibitory effects on Candida species as well as Gram-positive and Gram-negative bacteria, and exerts anti-inflammatory effects by stabilizing human erythrocyte membranes. Oxazepine can be used in research on infectious diseases.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C37H27N3O2
- 分子量:545.63
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Caco-2 | IC50 |
33.04 μM
|
Antiproliferative activity against human Caco-2 colorectal cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
Antiproliferative activity against human Caco-2 colorectal cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
|
36493622 |
| PANC-1 | IC50 |
50.87 μM
|
Antiproliferative activity against human PANC-1 pancreatic cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
Antiproliferative activity against human PANC-1 pancreatic cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
|
36493622 |
| MCF7 | IC50 |
55.69 μM
|
Antiproliferative activity against human MCF-7 breast cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
Antiproliferative activity against human MCF-7 breast cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
|
36493622 |
| MDA-MB-231 | IC50 |
46.83 μM
|
Antiproliferative activity against human MDA-MB-231 breast cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
Antiproliferative activity against human MDA-MB-231 breast cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
|
36493622 |
| A549 | IC50 |
40.50 μM
|
Antiproliferative activity against human A549 lung cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
Antiproliferative activity against human A549 lung cancer cells assessed as viability reduction by MTT assay after 48 hrs incubation.
|
36493622 |
| WISH | IC50 |
126 μM
|
Cytotoxicity against human WISH normal amniotic cells assessed by MTT assay after 48 hrs incubation.
Cytotoxicity against human WISH normal amniotic cells assessed by MTT assay after 48 hrs incubation.
|
36493622 |
体外実験
Oxazepine (compound 7a) (0-200 μM; 48 h) inhibits the proliferation of Caco-2 colorectal cancer cells with an IC50 of 33.04 μM, while showing lower cytotoxicity against WISH normal cells with an IC50 of 126 μM[4].
Oxazepine upregulates TSC2, Bax, and p53 and downregulates Bcl-2 in Caco-2 colorectal cancer cells[4].
Oxazepine (48 h) inhibits the PI3K/Akt/mTOR signaling pathway in Caco-2 colorectal cancer cells by reducing the phosphorylation of PI3K, Akt, and mTOR[4].
Oxazepine (IC12.5-IC50; 48 h) induces dose-dependent apoptotic morphological changes in Caco-2 colorectal cancer cells[4].
Oxazepine (IC12.5-IC50; 48 h) arrests Caco-2 colorectal cancer cells in the sub-G0/G1 phase in a dose-dependent manner, reaching 34.3% at the IC50[4].
Oxazepine (48 h) induces oxidative stress in Caco-2 colorectal cancer cells by increasing MDA and decreasing GSH[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Caco-2 colorectal cancer cells
-
Concentration:IC12.5, IC25, IC50
-
Incubation Time:48 h
-
Result:Caco-2 cells showed visible morphological signs of apoptosis in a dose-dependent manner, including cytoplasmic condensation and cell detachment.
Control cells appeared normal, spindle-shaped, and confluent.
-
Cell Line:Caco-2 colorectal cancer cells
-
Concentration:IC12.5, IC25, IC50
-
Incubation Time:48 h
-
Result:Induced dose-dependent accumulation of Caco-2 cells in the sub-G0/G1 phase: 10.8%, 19.9%, and 34.3% at IC12.5, IC25, and IC50, respectively, compared with 2.1% in control cells.
化学情報
-
分子量 545.63
-
分子式 C37H27N3O2
-
SMILES
O=C1N(C2=CC=C(C3=NC4=CC=CC=C4OC(/C=C/C5=CC=CC=C5)C3)C=C2)C(C6=CC=CC=C6)=NC7=C1C=CC=C7
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Che J, et al. Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment. Journal of medicinal chemistry. 2023 Oct 12;66(19):13530-13555. [Content Brief]
[2]. Anaissi-Afonso L, et al. Fused oxazepine-naphthoquinones as novel cytotoxic agents with diverse modes of action in yeast. Heliyon. 2024 Dec 30;10(24):e41105. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Oxazepine 関連分類
HY-162274 関連分類
Powered by Bioz